Cetuximab pharmacokinetics in end-stage kidney disease under hemodialysis

J Clin Oncol. 2008 Sep 1;26(25):4223-5. doi: 10.1200/JCO.2008.18.7674.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / pharmacokinetics*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / pharmacokinetics*
  • Cetuximab
  • Comorbidity
  • Enzyme-Linked Immunosorbent Assay
  • Head and Neck Neoplasms / complications
  • Head and Neck Neoplasms / drug therapy*
  • Humans
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / therapy*
  • Medical Oncology / methods
  • Middle Aged
  • Models, Statistical
  • Renal Dialysis
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Cetuximab